| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―03 |
Asymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective study |
Yanhong Wu, Shenghao Wu, Weijue Su, Junzhao Zhao, Liangliang Ma |
| 2 |
[GO] |
2024―Nov―20 |
Characterization of the gut microbiota in patients with SARS-CoV-2 infection during controlled ovarian stimulation |
Tianjin Yang, Guanjian Li, Huayan Yin, Longmei Wu, Yunxia Cao, Bing Song |
| 3 |
[GO] |
2023―Nov―22 |
Effects of SARS-CoV-2 infection on embryological outcomes in assisted reproductive technology during the Omicron epidemic |
Yuling Mao, Yachao Yao, Hongzi Du, Zheng Wang, Xueliang Zhou, Ming Zeng, et al. (+6) Chunyan Wang, Hanyan Liu, Yang Luo, Honghai Hong, Jianqiao Liu, Lei Li |
| 4 |
[GO] |
2021―Sep―27 |
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia |
Santosh Kumar Singh, Shailesh Singh, Rajesh Singh |
| 5 |
[GO] |
2021―May―21 |
COVID-19 in Africa: an ovarian victory? |
Osman A. Dufailu, Afrakoma Afriyie-Asante, Bernard Gyan, David Adu Kwabena, Helena Yeboah, Frank Ntiakoh, Meshach Asare-Werehene |
| 6 |
[GO] |
2021―Apr―27 |
Correction to: Incidence, clinical features, and outcomes of COVID-19 in Canada: Impact of sex and age |
Jacob O’Brien, Kevin Y. Du, Chun Peng |
| 7 |
[GO] |
2021―Feb―25 |
Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection |
Sima Chaudhari, Satyajit Dey Pereira, Meshach Asare-Warehene, Ritam Naha, Shama Prasada Kabekkodu, Benjamin K. Tsang, Kapaettu Satyamoorthy |
| 8 |
[GO] |
2021―Feb―20 |
Challenges and opportunities for ovarian cancer management in the epidemic of Covid-19: lessons learned from Wuhan, China |
Zhilan Chen, Chun Zhang, Jiu Yin, Xin Xin, Hemei Li, Yapei Wang, et al. (+2) Benjamin K. Tsang, Qinghua Zhang |
| 9 |
[GO] |
2021―Feb―20 |
Fertility care amidst the COVID19 pandemic: the American experience |
Austin D. Schirmer, Jennifer F. Kawwass, Eli Y. Adashi |
| 10 |
[GO] |
2021―Feb―08 |
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied? |
Antonio Macciò, Sara Oppi, Clelia Madeddu |
| 11 |
[GO] |
2020―Nov―27 |
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective |
Mitko Madjunkov, Michal Dviri, Clifford Librach |
| 12 |
[GO] |
2020―Nov―24 |
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age |
Jacob O’Brien, Kevin Y. Du, Chun Peng |
| 13 |
[GO] |
2020―Sep―11 |
Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience |
Yuya Nogami, Yusuke Kobayashi, Kosuke Tsuji, Megumi Yokota, Hiroshi Nishio, Masaru Nakamura, et al. (+5) Wataru Yamagami, Tohru Morisada, Eiichiro Tominaga, Kouji Banno, Daisuke Aoki |
| 14 |
[GO] |
2020―Jul―19 |
Withaferin A: a potential therapeutic agent against COVID-19 infection |
Alex R. Straughn, Sham S. Kakar |
